LPA and cardiovascular disorder: The growing recognition of Lp(a)’s importance is already reflected in its inclusion in various clinical guidelines and consensus statements for other cardiovascular disease, such as the Lipoprotein(a) Consensus 2022 by the European Atherosclerosis Society [128] and the 2021 Guidelines for the Management of Dyslipidaemia for the Prevention of Cardiovascular Disease in Adults issued by the Canadian Cardiovascular Society [129].